FDA guidance updates postmarket surveillance program

08/18/2011 | MassDevice.com (Boston)

The FDA has issued guidance outlining the types of devices that may be eligible for postmarket surveillance as well as how manufacturers should comply with the program. The guidance, which will be up for comment over the next three months, also recommends that the 36-month surveillance period be extended for pediatric devices.

View Full Article in:

MassDevice.com (Boston)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
CareFusion
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ
Project Manager RA - 15000003MD
Abbott
Santa Clara, CA
Director, Site Quality Management
CareFusion
Minneapolis, MN